MGP
TARS icon

M&G plc’s Tarsus Pharmaceuticals TARS Stock Holding History

M&G plc’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-166,364
Closed -$11.6M – 401
2026
Q1 		$11.6M Buy
+166,364
New +$11.6M 0.06% 193

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

M&G plc's TARS Position: Q2 2026 in Review

M&G plc sold out of Tarsus Pharmaceuticals (TARS) in Q2 2026, closing a stake of 166,364 shares — an estimated $11.6M sold.

M&G plc first reported a position in TARS in Q1 2026 and held it in 1 quarter. The position peaked at $11.6M in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • M&G plc reported no remaining Tarsus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • M&G plc sold 166,364 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $11.6M.
  • M&G plc first reported a position in Tarsus Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • M&G plc's Tarsus Pharmaceuticals position peaked at $11.6M in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.